The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Precision Biosciences Inc shares valued at $21,082 were purchased by Buehler Kevin on Dec 27 ’24. At $4.88 per share, Buehler Kevin acquired 4,320 shares. The insider’s holdings grew to 8,712 shares worth approximately $33192.72 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Kelly John Alexander purchased 2,113 shares, netting a total of over 10,037 in proceeds. Following the buying of shares at $4.75 each, the insider now holds 40,186 shares.
Before that, Brown Melinda had added 3,016 shares to its account. In a trade valued at $13,723, the Director bought Precision Biosciences Inc shares for $4.55 each. Upon closing the transaction, the insider’s holdings increased to 3,016 shares, worth approximately $27500.58.
As published in their initiating research note from Guggenheim on April 30, 2024, Precision Biosciences Inc [DTIL] has been a Buy and the price target has been revised to $19. Analysts at BMO Capital Markets started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid June. As of June 09, 2022, William Blair has decreased its “an Outperform” rating to a “Mkt perform” for DTIL.
Analyzing DTIL Stock Performance
During the last five days, there has been a drop of approximately -15.33%. Over the course of the year, Precision Biosciences Inc shares have dropped approximately -65.21%. Shares of the company reached a 52-week high of $19.43 on 02/29/24 and a 52-week low of $3.61 on 12/31/24. A 50-day SMA is recorded $6.81, while a 200-day SMA reached $9.68. Nevertheless, trading volume fell to 0.53 million shares from 78176.0 shares the previous day.
Support And Resistance Levels for Precision Biosciences Inc (DTIL)
According to the 24-hour chart, there is a support level at 3.45, which, if violated, would cause prices to drop to 3.08. In the upper region, resistance lies at 4.34. The next price resistance is at 4.86. RSI (Relative Strength Index) is 27.07 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.50, which suggests the price will decrease in the coming days. Percent R is at 92.20%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
